Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
14087-31-1
Molecular formula
C11H20O10
Molecular weight
312.27 g/mol
Drug class
Diagnostic substratelactase activity test agent
Mechanism of action
Gaxilose (4-galactosylxylose) is an orally administered synthetic disaccharide substrate for intestinal lactase. Hydrolysis by lactase releases D-xylose and galactose; measurement of D-xylose in serum or urine provides an indirect assessment of intestinal lactase activity.
Indications / reported uses
Diagnostic assessment of intestinal lactase activity and lactose malabsorption using a serum or urine xylose measurement after oral administration, where the test is available and validated.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Gaxilose PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Gaxilose Permitted Daily Exposure (PDE) report (the Gaxilose PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Gaxilose Occupational Exposure Limit (OEL) report (the Gaxilose OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.